Cytomegalovirus belongs to the herpesviridae family and is a double-stranded DNA virus. This virus mainly causes asymptomatic infections or sometimes causes mild flu like symptoms; and later remains latent throughout life, which may reactivate. Thus, this virus can remain as a lifelong companion for some individuals and can be a silent killer for the others. Cytomegalovirus (CMV) infection is characterized by the development of such antibodies, which develop due to the infection of the virus that stays in an individual’s body throughout his life.
This report contains market size and forecasts of Cytomegalovirus (CMV) Diagnostic in Global, including the following market information:
Global Cytomegalovirus (CMV) Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cytomegalovirus (CMV) Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cytomegalovirus (CMV) Diagnostic include Abbott Laboratories, bioMérieux, BD Biosciences, Bio-Rad Laboratories, Roche, Bioneer Corp, Siemens Healthcare, Thermo Fisher Scientific and Realstar Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cytomegalovirus (CMV) Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cytomegalovirus (CMV) Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cytomegalovirus (CMV) Diagnostic Market Segment Percentages, by Type, 2021 (%)
Blood
Urine
Global Cytomegalovirus (CMV) Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cytomegalovirus (CMV) Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Centers and Clinics
Others
Global Cytomegalovirus (CMV) Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cytomegalovirus (CMV) Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cytomegalovirus (CMV) Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cytomegalovirus (CMV) Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
bioMérieux
BD Biosciences
Bio-Rad Laboratories
Roche
Bioneer Corp
Siemens Healthcare
Thermo Fisher Scientific
Realstar Group
Merck
Qiagen
Guangdong Hybribio
Sansure Biotech